LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 59.42 | 21.74 | 232 | 6125 | 0.0379 | 0.3377 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 59.42 | 21.74 | 1330 | 6125 | 0.2171 | 0.6578 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 62.39 | 21.74 | 1355 | 6112 | 0.2217 | 0.6619 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 62.39 | 21.74 | 1373 | 6112 | 0.2246 | 0.6646 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 62.39 | 21.74 | 237 | 6112 | 0.0388 | 0.3413 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 62.39 | 21.74 | 1379 | 6112 | 0.2256 | 0.6655 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 64.36 | 21.74 | 1385 | 6191 | 0.2237 | 0.6645 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 64.36 | 21.74 | 1398 | 6191 | 0.2258 | 0.6664 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 64.36 | 21.74 | 235 | 6191 | 0.0380 | 0.3390 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 64.36 | 21.74 | 1354 | 6191 | 0.2187 | 0.6599 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 66.33 | 21.74 | 1435 | 6235 | 0.2301 | 0.6706 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 66.33 | 21.74 | 1454 | 6235 | 0.2332 | 0.6733 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 66.33 | 21.74 | 253 | 6235 | 0.0406 | 0.3507 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 66.33 | 21.74 | 1377 | 6235 | 0.2208 | 0.6622 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 68.30 | 21.74 | 1468 | 6244 | 0.2351 | 0.6751 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 68.30 | 21.74 | 1483 | 6244 | 0.2375 | 0.6772 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 68.30 | 21.74 | 259 | 6244 | 0.0415 | 0.3545 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 68.30 | 21.74 | 1361 | 6244 | 0.2180 | 0.6596 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 70.27 | 21.74 | 1508 | 6201 | 0.2432 | 0.6817 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 70.27 | 21.74 | 1521 | 6201 | 0.2453 | 0.6834 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 70.27 | 21.74 | 287 | 6201 | 0.0463 | 0.3721 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 70.27 | 21.74 | 1452 | 6201 | 0.2341 | 0.6739 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 72.24 | 21.74 | 1513 | 6162 | 0.2455 | 0.6833 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 72.24 | 21.74 | 1531 | 6162 | 0.2485 | 0.6858 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 72.24 | 21.74 | 279 | 6162 | 0.0453 | 0.3679 | MN20160310_N01 | N22 |